AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Amplitude Surgical

Earnings Release Jul 6, 2015

1108_iss_2015-07-06_aafb6274-e624-4caa-8d90-54cb21c871cd.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Amplitude Surgical announces its financial calendar for 2015/16

Valence, 6 July 2015 – Amplitude Surgical (Euronext - FR0012789667), a leading French player in the international market for lower limb prostheses, today announces its schedule for the publication of financial information for 2015/16.

Événements Dates *
2014/15 Full-Year Sales September 16, 2015
2014/15 Full-Year Results October 21, 2015
2015/16 1Q Sales November 12, 2015
2015/16 1H Sales February 3, 2016
2015/16 1H Results March 9, 2016
2015/16 3Q Sales April 27, 2016
2015/16 Full-Year Sales July 20, 2016

* Subject to modification. Press releases are published after market closes.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. Amplitude Surgical distributes its products in more than 30 countries and had a workforce of 210 staff on December 31, 2014. Amplitude Surgical recorded revenue of 58.2 million euros for its financial year ending on June 30, 2014, with average annual growth of around 15% since 2005 and an average EBITDA margin of more than 20% over 2005-2014.

Contacts:

NewCap Investor Relations Florent Alba [email protected] +33 (0)1 44 71 98 55

NewCap Media Relations Nicolas Merigeau [email protected] +33 (0)1 44 71 98 55

Talk to a Data Expert

Have a question? We'll get back to you promptly.